Answers are grounded in this paper and cite their sources.
To the Editor: Inflammatory bowel diseases (IBD) have been accepted as an independent risk factor for venous thromboembolism (VTE).1 Although the exact pathomechanism is not well known, there is strong evidence that the inflammatory process is intimately linked with coagulation activation.2 Usually, VTE manifests as deep venous thrombosis of the lower limb and/or pulmonary embolism. However, some cases of IBD patients have been described with thrombus formation at uncommon sites such as the portal or mesenteric vein.1,3,4 We report on a 35-year-old female who developed thrombosis of the portal vein during an acute flare-up of ulcerative colitis (UC) complicated by severe bleeding from gastric varices. Our patient was suffering from extensive colitis for 14 years when she once again was admitted to a local hospital due to an acute flare-up of UC. She presented with abdominal pain and bloody diarrhea (clinical activity index (CAI)5 of 10) that had started several weeks ago. Despite a clear reduction of stool frequency under treatment with intravenous prednisolone (50 mg/d) and oral mesalamine (3 × 1000 mg/d), left upper quadrant pain persisted and was even accompanied by nausea and emesis. Abdominal ultrasound was highly suggestive of portal vein thrombosis (PVT), the reason for which anticoagulant therapy with low-molecular-weight heparin was initiated. Five days later the patient suddenly presented with hematemesis. Esophagogastroduodenoscopy revealed bleeding gastric fundus varices that were successfully managed by injection of histoacryl. Two days later a second episode of hematemesis was treated by insertion of a Sengstaken-Blakemore tube and the infusion of two red cell packages. Under perfusion of somatostatin (6 mg/d) via a central venous line the patient was finally transferred to our clinic. At physical examination she presented with left upper quadrant abdominal pain and clearly palpable splenomegaly. Laboratory investigations revealed anemia (hemoglobin 9.4 g/dL) and elevations of white blood cell count (17.5 × 109/L), C-reactive protein (43 mg/L), and lactate dehydrogenase (285 U/L). Liver function tests were slightly elevated as well (below 1.5 × upper limit of normal range). Platelet count was within the normal range. Abdominal computed tomography (CT) confirmed the diagnosis of PVT with involvement of the splenic vein and the proximal part of the superior mesenteric vein (Fig. 1). In the meanwhile, the portal vein showed a cavernous transformation pointing to a chronic thrombotic condition. Extensive laboratory workup for thrombophilia including Factor V Leiden, prothrombin G20210A mutation, activity of coagulation factors and natural coagulation inhibitors, hyperhomocysteinemia, and lupus anticoagulans showed no abnormalities. In the absence of other inherited or acquired prothrombotic risk factors we therefore consider the flare-up of UC to be the most likely trigger of PVT development in our patient. Helical computed tomography; venous phase after injection of contrast medium. Arrow: Portal vein thrombosis with cavernous transformation. Due to the chronic state of PVT, further treatment options were limited to secondary bleeding prophylaxis by another elective histoacryl injection therapy of a fundus varice (Fig. 2). Anticoagulation, although reasonable, was abandoned due to bleeding risks. During a follow-up of 2 1/2 years, no further bleeding episode occurred. However, signs of portal hypertension proceeded, leading to multiple esophageal varices (Stage III, in part with red spot sign) requiring treatment with, altogether, 16 band ligations within multiple sessions. Splenomegaly was progredient as well (from 166–200 mm in diameter), accompanied by splenorenal shunt development and massive collateralization to the ovarian and uterine veins. Fundus varice with red spot sign 5 days after histoacryl injection. More than 30 cases of PVT have been reported in both active UC and active Crohn's disease; however, only three similar cases complicated by variceal bleeding have been mentioned in the literature.3,4 One of them obviously did not require any endoscopic intervention,4 and of the other two no details are available.3 Finally, in a fourth patient without bleeding complication band ligation therapy due to prominent esophageal varices was performed.6 In conclusion, our patient is an exceptional and well-documented example for one of the rare but life-threatening manifestations of thrombosis triggered by active IBD. Increased awareness of possible PVT in the setting of active IBD with left upper quadrant abdominal pain and emesis might help to diagnose PVT in an early stage, when treatment options such as thrombolytic therapy, anticoagulation, or shunt insertion show a better outcome.7
No takes yet. Share an insight, caveat, or question.
Palkovits et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: